Search for: "Pfizer Pharmaceutical" Results 101 - 120 of 1,414
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2021, 5:03 am by Lisa Larrimore Ouellette
Originally, TRIPS only permitted compulsory licensing for domestic production—and although many countries did have the ability to produce their own pharmaceuticals, not all did. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]
Nativa vs Pfizer (Sunitinib) Pfizer filed a patent infringement action against Nativa as a result of Nativa launching a product after participatin [read post]
His Honour disagreed with the Commissioner’s submissions about the implications of Pfizer, and was not bound by the Patent Office decisions that followed, such as GD Searle. [read post]
30 Jun 2021, 10:31 am by Lisa Larrimore Ouellette
The pharmaceutical companies themselves choose, in their best scientific judgment, the right dosage and route of administration for their new products. [read post]
11 Jun 2021, 12:32 pm by Tom Kosakowski
He served as the pharmaceutical giant’s first Chief Ombudsman, and talks about his design work involving the function to address employment issues, including using alternative dispute resolution. [read post]
27 May 2021, 9:56 am by Nicholas Weaver
But the research group I was then a member of showed Pfizer how to eliminate the Viagra spam problem. [read post]
21 May 2021, 11:53 am by Matt Gluck
Pharmaceutical companies Pfizer and BioNTech said on Friday that they would send two billion doses of their jointly produced coronavirus vaccine to middle- and low-income countries during the next 18 months, writes the Associated Press. [read post]
16 May 2021, 9:15 am by Imron Aly
Predictably, major pharmaceutical companies, including the three pharmaceutical manufacturers with vaccines approved for use in the United States — Pfizer, Moderna, and Johnson & Johnson —have lobbied against easing patent rules. [read post]
14 May 2021, 5:20 am by Simon Lester
Tai's response was perhaps a little less subtle as a nudge to the pharmaceutical industry to go in that direction ("There is a lot that they could do voluntarily that would obviate what we would need to do at the WTO"). [read post]
14 May 2021, 3:42 am by Simon Lester
As a final point, her characterization of the differences between the pharmaceutical companies was interesting. [read post]
9 May 2021, 6:55 pm by Dennis Crouch
Germany helped fund the Pfizer/Bio-N-Tech vaccine and has expressed concern that a broad waiver could undermine innovation. [read post]
9 May 2021, 4:35 am by Keith Mallinson
The first-to-market and highly efficacious BioNTech/Pfizer vaccine is a stellar example of how the patent system works. [read post]
9 May 2021, 4:35 am by Keith Mallinson
The first-to-market and highly efficacious BioNTech/Pfizer vaccine is a stellar example of how the patent system works. [read post]
5 May 2021, 12:56 pm by Dennis Crouch
Thus,  the TRIPS dispute resolution process does not provide Pfizer standing to sue India for violating IP rights guaranteed under TRIPS; Rather Pfizer could only lobby to the U.S. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
Last week, Pfizer announced its vaccine generated revenues of almost 3 billion euros in the first three months of 2021 and is expected to hit 21 billion euros this year, accounting for more than one third of Pfizer’s sales. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
Last week, Pfizer announced its vaccine generated revenues of almost 3 billion euros in the first three months of 2021 and is expected to hit 21 billion euros this year, accounting for more than one third of Pfizer’s sales. [read post]
1 May 2021, 9:41 pm by Patent Docs
Brown of Dell Technologies, and Sharon Reiche of Pfizer will explore the extent to which governments should assume patent licensing powers to make crucial medical related supplies available, and discuss the voluntary IP licensing initiatives taken by companies in the pharmaceutical, medical device, and IT industries in meeting the challenges of the current pandemic. [read post]
1 May 2021, 8:00 am
It’s also very literal, like a budget brand would be. 'Do you really have to call yourself modern if you’re selling pharmaceuticals that are in fact based on cutting-edge technologies?... [read post]